{"date":"2025-01-28","count":1,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6696-2025-01-28-0748-1hfwggp","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-01-28","time":"07:48:39","subject":"代重要子公司Belite Bio, Inc公告董事會決議通過向美國證券交易委員會遞交Form F-3股份登記表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-01-28 07:48，「代重要子公司Belite Bio, Inc公告董事會決議通過向美國證券交易委員會遞交Form F-3股份登記表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}